Drug intelligence / Profile preview

N-(3-carboxypropanoyl)-L-phenylalanyl-3-carboxy-O-(carboxymethyl)-N-pentyl-L-tyrosinamide

Development stage
Unknown
Modality
Peptides, Small Molecules
01

Overview

N-(3-Carboxypropanoyl)-L-phenylalanyl-3-carboxy-O-(carboxymethyl)-N-pentyl-L-tyrosinamide is a synthetic small molecule with the molecular formula C30H37N3O10 and a molecular weight of approximately 599.6 g/mol[1][2][3]. It is classified as an experimental compound and listed in chemical databases such as PubChem (CID 445785), DrugBank (DB04525), and ChEMBL (CHEMBL175198)[1][2]. The compound belongs to the class of dipeptides, containing two amino acids linked by a peptide bond[1][2]. There are no approved therapeutic indications, clinical trials, or known mechanisms of action reported for this molecule. Its pharmacological activity, mechanism of action, developer information, and potential clinical applications remain uncharacterized in public scientific resources[1][2].

Other names
2-(carboxymethoxy)-5-((2S)-2-((2S)-2-(3-carboxypropanamido)-3-phenylpropanamido)-2-(pentylcarbamoyl)ethyl)benzoic acid2-(carboxymethoxy)-5-[(2S)-2-[[(2S)-2-(3-carboxypropanoylamino)-3-phenylpropanoyl]amino]-3-oxo-3-(pentylamino)propyl]benzoic acid
02

Targets

PTPN1 (Protein tyrosine phosphatase 1B)

Beyond the preview

Go deeper on N-(3-carboxypropanoyl)-L-phenylalanyl-3-carboxy-O-(carboxymethyl)-N-pentyl-L-tyrosinamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-(3-carboxypropanoyl)-L-phenylalanyl-3-carboxy-O-(carboxymethyl)-N-pentyl-L-tyrosinamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call